| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Australia | 3 | |
| #2 | Canada | 3 | |
| #3 | China | 3 | |
| #4 | United States | 3 | |
| #5 | EPO (European Patent Office) | 2 | |
| #6 | Japan | 2 | |
| #7 | Republic of Korea | 2 | |
| #8 | Singapore | 2 | |
| #9 | WIPO (World Intellectual Property Organization) | 2 | |
| #10 | Israel | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Medical technology | |
| #3 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Object sterilising | |
| #4 | Microorganisms | |
| #5 | Implantable devices |
| # | Name | Total Patents |
|---|---|---|
| #1 | Iwamiya Takahiro | 23 |
| #2 | Matsuura Katsuhisa | 9 |
| #3 | Suzuki Masaya | 4 |
| #4 | Osugi Tomoyuki | 4 |
| Publication | Filing date | Title |
|---|---|---|
| CA3110831A1 | Method for producing fibroblast, and g-csf-positive fibroblast mass | |
| CA3032654A1 | Composition for injection which can be used for treatment of heart diseases and contains fibroblasts, and method for producing fibroblast for therapy use | |
| CA2954743A1 | Cardiac cell culture material |